Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global POC Infectious Diseases Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Flu
  • 1.3.3 Adenovirus
  • 1.3.4 Malaria
  • 1.3.5 Streptococcal Bacteremia
  • 1.3.6 Tuberculosis (TB)
  • 1.3.7 Occult Blood
  • 1.3.8 HIV
• 1.4 Market Segment by Application
  • 1.4.1 Global POC Infectious Diseases Market Share by Application (2019-2025)
  • 1.4.2 Hospital& Clinics
  • 1.4.3 Clinical Diagnostic Laboratories
  • 1.4.4 Homecare Settings
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global POC Infectious Diseases Production Value 2014-2025
  • 2.1.2 Global POC Infectious Diseases Production 2014-2025
  • 2.1.3 Global POC Infectious Diseases Capacity 2014-2025
  • 2.1.4 Global POC Infectious Diseases Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global POC Infectious Diseases Market Size CAGR of Key Regions
  • 2.2.2 Global POC Infectious Diseases Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global POC Infectious Diseases Capacity by Manufacturers
  • 3.1.2 Global POC Infectious Diseases Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 POC Infectious Diseases Revenue by Manufacturers (2014-2019)
  • 3.2.2 POC Infectious Diseases Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI)
• 3.3 POC Infectious Diseases Price by Manufacturers
• 3.4 Key Manufacturers POC Infectious Diseases Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into POC Infectious Diseases Market
• 3.6 Key Manufacturers POC Infectious Diseases Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Flu Production and Production Value (2014-2019)
  • 4.1.2 Adenovirus Production and Production Value (2014-2019)
  • 4.1.3 Malaria Production and Production Value (2014-2019)
  • 4.1.4 Streptococcal Bacteremia Production and Production Value (2014-2019)
  • 4.1.5 Tuberculosis (TB) Production and Production Value (2014-2019)
  • 4.1.6 Occult Blood Production and Production Value (2014-2019)
  • 4.1.7 HIV Production and Production Value (2014-2019)
• 4.2 Global POC Infectious Diseases Production Market Share by Type
• 4.3 Global POC Infectious Diseases Production Value Market Share by Type
• 4.4 POC Infectious Diseases Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global POC Infectious Diseases Consumption by Application

6 Production by Regions

• 6.1 Global POC Infectious Diseases Production (History Data) by Regions 2014-2019
• 6.2 Global POC Infectious Diseases Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States POC Infectious Diseases Production Growth Rate 2014-2019
  • 6.3.2 United States POC Infectious Diseases Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States POC Infectious Diseases Import & Export
• 6.4 European Union
  • 6.4.1 European Union POC Infectious Diseases Production Growth Rate 2014-2019
  • 6.4.2 European Union POC Infectious Diseases Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union POC Infectious Diseases Import & Export
• 6.5 China
  • 6.5.1 China POC Infectious Diseases Production Growth Rate 2014-2019
  • 6.5.2 China POC Infectious Diseases Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China POC Infectious Diseases Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 POC Infectious Diseases Consumption by Regions

• 7.1 Global POC Infectious Diseases Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States POC Infectious Diseases Consumption by Type
  • 7.2.2 United States POC Infectious Diseases Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union POC Infectious Diseases Consumption by Type
  • 7.3.2 European Union POC Infectious Diseases Consumption by Application
• 7.4 China
  • 7.4.1 China POC Infectious Diseases Consumption by Type
  • 7.4.2 China POC Infectious Diseases Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World POC Infectious Diseases Consumption by Type
  • 7.5.2 Rest of World POC Infectious Diseases Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Alere
  • 8.1.1 Alere Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of POC Infectious Diseases
  • 8.1.4 POC Infectious Diseases Product Introduction
  • 8.1.5 Alere Recent Development
• 8.2 Meridian Bioscience
  • 8.2.1 Meridian Bioscience Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of POC Infectious Diseases
  • 8.2.4 POC Infectious Diseases Product Introduction
  • 8.2.5 Meridian Bioscience Recent Development
• 8.3 Orasure Technologies
  • 8.3.1 Orasure Technologies Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of POC Infectious Diseases
  • 8.3.4 POC Infectious Diseases Product Introduction
  • 8.3.5 Orasure Technologies Recent Development
• 8.4 Trinity Biotech
  • 8.4.1 Trinity Biotech Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of POC Infectious Diseases
  • 8.4.4 POC Infectious Diseases Product Introduction
  • 8.4.5 Trinity Biotech Recent Development
• 8.5 Abbott
  • 8.5.1 Abbott Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of POC Infectious Diseases
  • 8.5.4 POC Infectious Diseases Product Introduction
  • 8.5.5 Abbott Recent Development
• 8.6 Beckman Coulter/ Danaher
  • 8.6.1 Beckman Coulter/ Danaher Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of POC Infectious Diseases
  • 8.6.4 POC Infectious Diseases Product Introduction
  • 8.6.5 Beckman Coulter/ Danaher Recent Development
• 8.7 Becton Dickinson
  • 8.7.1 Becton Dickinson Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of POC Infectious Diseases
  • 8.7.4 POC Infectious Diseases Product Introduction
  • 8.7.5 Becton Dickinson Recent Development
• 8.8 Biomerieux
  • 8.8.1 Biomerieux Company Details
  • 8.8.2 Company Description and Business Overview
  • 8.8.3 Production and Revenue of POC Infectious Diseases
  • 8.8.4 POC Infectious Diseases Product Introduction
  • 8.8.5 Biomerieux Recent Development
• 8.9 Bio-Rad
  • 8.9.1 Bio-Rad Company Details
  • 8.9.2 Company Description and Business Overview
  • 8.9.3 Production and Revenue of POC Infectious Diseases
  • 8.9.4 POC Infectious Diseases Product Introduction
  • 8.9.5 Bio-Rad Recent Development
• 8.10 Cepheid
  • 8.10.1 Cepheid Company Details
  • 8.10.2 Company Description and Business Overview
  • 8.10.3 Production and Revenue of POC Infectious Diseases
  • 8.10.4 POC Infectious Diseases Product Introduction
  • 8.10.5 Cepheid Recent Development
• 8.11 Diamedix
• 8.12 Diasorin
• 8.13 Eiken Chemical
• 8.14 Enzo Biochem

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global POC Infectious Diseases Capacity, Production Forecast 2019-2025
  • 9.1.2 Global POC Infectious Diseases Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global POC Infectious Diseases Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global POC Infectious Diseases Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global POC Infectious Diseases Production Forecast by Type
  • 9.7.2 Global POC Infectious Diseases Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 POC Infectious Diseases Sales Channels
  • 10.2.2 POC Infectious Diseases Distributors
• 10.3 POC Infectious Diseases Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
In 2019, the market size of POC Infectious Diseases is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for POC Infectious Diseases.

This report studies the global market size of POC Infectious Diseases, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the POC Infectious Diseases production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Alere
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Abbott
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem

Market Segment by Product Type
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV

Market Segment by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the POC Infectious Diseases status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key POC Infectious Diseases manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of POC Infectious Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025